Freestone Grove Partners »

Oruka Therapeutics shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.1M 22k 95.17

More positions owned by Freestone Grove Partners

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Us Bancorp Com New (USB)
Raytheon Technologies Corp (RTX)
Ge Aerospace Com New (GE)
Crane Company Common Stock (CR)
American Intl Group Com New (AIG)
Snowflake Com Shs (SNOW)
Fortune Brands (FBIN)
Johnson & Johnson (JNJ)
Abbott Laboratories (ABT)
Axis Cap Hldgs SHS (AXS)
Keurig Dr Pepper (KDP)
Microsoft Corporation (MSFT)

View all positions for Freestone Grove Partners

Top funds holding Oruka Therapeutics

FMR
BlackRock
VR Adviser
Fairmount Funds Management
Rtw Investments
Vanguard Capital Management
Paradigm Biocapital Advisors
Deep Track Capital
Bellevue Group
Franklin Resources
State Street Corporation
Remedium Capital Partners
RA Capital Management
Viking Global Investors
Geode Capital Management

View all funds holding Oruka Therapeutics